Home
http://www.virbac.fr/ http://www.boehringer-ingelheim.com/ http://www.novartis.com/ http://www.animalhealth.bayerhealthcare.com/
vetcontact
Vetrinär
Tiermedizin
  WELCOME  
vetcontact
Vetrinär
Tiermedizin
  Home  
  Login / Newsletter  
vetcontact
Vetrinär
Tiermedizin
  CONTACTS  
vetcontact
Vetrinär
Tiermedizin
  Classifieds  
  New Products  
  VetCompanies  
  VetSchools  
vetcontact
Vetrinär
Tiermedizin
  PROFESSION  
vetcontact
Vetrinär
Tiermedizin
  Edutainment  
  VetAgenda  
  Presentations  
  Posters  
  ESAVS  
  Specialisation  
vetcontact
Vetrinär
Tiermedizin
  INSIGHT  
vetcontact
Vetrinär
Tiermedizin
  Congress News  
  Picture Galleries  
  Interferon  
vetcontact
Vetrinär
Tiermedizin
  PRODUCTS  
vetcontact
Vetrinär
Tiermedizin
  Bayer  
  Boehringer Ing.  
  Novartis  
  Virbac

 
  Simply book for less...  
    

Bovine    Equine    Small Animal Practice    Swine Practice    Articles    Vetjournal    
deutsch english español polski francais
Home / WELCOME / Archiv / Small Animal Practice /     
 
Vascular endothelial growth factor and receptors in canine mastocytoma cells
Mastocytomas are the most common malignant neoplasias in dogs and much more aggressive than in other species. Recently, the expression of vascular endothelial growth factor (VEGF) - a major regulator of angiogenesis and a potential autocrine growth factor for neoplastic cells in various malignancies - and its receptors have been investigated. These neoplasies show a very unusual expression!

In the present study, we have investigated expression of VEGF and VEGF receptors in canine mastocytomas and the canine mastocytoma cell line C2.

As assessed by immunostaining of tissue sections and cytospin slides, primary neoplastic mast cells (MC) and C2 cells were found to express the VEGF protein.

In Northern blot and RT-PCR experiments, C2 cells expressed VEGF mRNA in a constitutive manner. VEGF mRNA expression in C2 cells was counteracted by LY294002 and rapamycin, suggesting involvement of the PI3-kinase/mTOR pathway.

Moreover, C2 cells were found to express VEGF receptor-1 (Flt-1) and VEGF receptor-2 (KDR).

However, recombinant VEGF failed to promote (3)H-thymidine uptake in C2 cells, and a neutralizing anti-VEGF antibody (bevacizumab) failed to downregulate spontaneous proliferation in these cells.

In addition, rapamycin decreased the expression of VEGF in C2 cells at the mRNA and protein level without suppressing their proliferation.

Together, canine mastocytoma cells express VEGF as well as VEGF receptors. However, despite co-expression of VEGF and its receptors, VEGF is not utilized as an autocrine growth regulator by canine mastocytoma cells.



Source: Rebuzzi L, et al (2007): Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells. In: Vet Immunol Immunopathol. 2007 Feb 15;115(3-4):320-33. Epub 2006 Nov 17.



Tell a friend   |   Print version   |   Send this article

SMALL ANIMAL PRACTICE

Closed suction drainage in dogs with septic peritonitis
How is the survival rate of dogs with septic peritonitis of confirmed gastrointestinal origin treated with closed suction drainage? 20 dogs with septic peritonitis were included in this retrospective case series.

  • Equine glaucoma - histopathologic findings
  • Laparoscopic versus open cystopexy in dogs
  • Sliding humeral osteotomy (SHO) in dogs - long term effects
  • Vessel Sealant Device for Cystic Duct Ligation in the Dog
  • Ciclosporin for canine generalized discoid lupus erythematosus
  • Correlation of murmur intensity and disease severity in small dogs
  • Silicone tracheal stoma stents for temporary tracheostomy
  • D- and L-lactate in the blood of healthy rabbits
  • Surgical biopsy of the canine and feline pancreas - complications and results
  • Novel technique for cementless total hip replacement in juvenile dogs
  • COGS in the dogmembers
  • Blood glucose in small animals with acute arterial thrombembolismmembers


  • [ Home ] [ About ] [ Contact / Request ][ Disclaimer ]

    Copyright © 2001-2013 VetContact GmbH
    All rights reserved